• New York Study Suggests Sleep Apnea Increases Risk of a Person Developing Alzheimer’s
  • GAP Foundation Strives to Boost Clinical Trial Participation in U.S. Alzheimer’s Trials
  • Bill Gates Joins Efforts to Develop New Therapy Strategies for Alzheimer’s Disease
  • Potential Therapy, CT1812, Seen as Safe and Able to Target Disease Markers, Cognition Reports
  • Alkahest Sees Plasma Infusions as Potential Treatment for Mild to Moderate Alzheimer’s
  • Biogen, Citing New Phase 1 Data, Says Aducanumab Reduces Amyloid Plaques in Alzheimer’s
  • Anavex ‘Cautiously Optimistic’ After Noting Cognitive Improvement in Alzheimer’s Treatment
  • Pimavanserin Aids Alzheimer’s Patients with Severe Psychosis, Acadia Reports
  • New Phase 3 Study Planned for Possible Treatment of Agitation Linked to Alzheimer’s
  • Using Opioids Does Not Increase Risk of Alzheimer’s Disease, Study Shows
  • Alzheimer’s Trial Failures May Be Due to Compound That Promoted Amyloid Buildup, Study Says
  • Women’s Alzheimer’s Movement, A+E Networks to Host NYC ‘Brain Health Summit’